Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $515.90 | 6 | 61.9% |
| Food and Beverage | $316.93 | 8 | 38.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $181.98 | 2 | $0 (2023) |
| Incyte Corporation | $175.94 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $99.75 | 1 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $94.87 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $82.99 | 1 | $0 (2023) |
| Aveo Pharmaceuticals, Inc. | $74.99 | 1 | $0 (2024) |
| GENZYME CORPORATION | $35.47 | 1 | $0 (2024) |
| EMD Serono, Inc. | $22.68 | 1 | $0 (2023) |
| Novo Nordisk Inc | $17.75 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $17.68 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.41 | 3 | Incyte Corporation ($93.95) |
| 2023 | $435.48 | 7 | Seagen Inc. ($99.99) |
| 2022 | $181.73 | 3 | Incyte Corporation ($81.99) |
| 2021 | $11.21 | 1 | E.R. Squibb & Sons, L.L.C. ($11.21) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $35.47 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $93.95 | General |
| 04/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 12/09/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 09/22/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 06/07/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $99.75 | General |
| Category: Oncology | ||||||
| 06/01/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $94.87 | General |
| 04/11/2023 | EMD Serono, Inc. | TEPMETKO (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $82.99 | General |
| 02/22/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Hematology | ||||||
| 10/11/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $81.99 | General |
| 10/05/2022 | Seagen Inc. | — | Education | In-kind items and services | $81.99 | General |
| 04/27/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Obesity | ||||||
| 08/20/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.21 | General |
| Category: Cardiovascular | ||||||
About Dr. Noha Soror, MD
Dr. Noha Soror, MD is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1104386176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noha Soror, MD has received a total of $832.83 in payments from pharmaceutical and medical device companies, with $204.41 received in 2024. These payments were reported across 14 transactions from 12 companies. The most common payment nature is "Education" ($515.90).
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 03/25/2019
- Last Updated 06/27/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1104386176
Products in Payments
- CALQUENCE (Drug) $99.75
- FOTIVDA (Drug) $74.99
- SARCLISA (Biological) $35.47
- TEPMETKO (Drug) $22.68
- Wegovy (Drug) $17.75
- SCEMBLIX (Drug) $17.68
- Pomalyst (Drug) $17.52
- ELIQUIS (Drug) $11.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791